JP2021511327A5 - - Google Patents
Info
- Publication number
- JP2021511327A5 JP2021511327A5 JP2020539797A JP2020539797A JP2021511327A5 JP 2021511327 A5 JP2021511327 A5 JP 2021511327A5 JP 2020539797 A JP2020539797 A JP 2020539797A JP 2020539797 A JP2020539797 A JP 2020539797A JP 2021511327 A5 JP2021511327 A5 JP 2021511327A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- quinazolin
- piperidine
- fluoro
- methylphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2018051283 | 2018-01-19 | ||
| EPPCT/EP2018/051283 | 2018-01-19 | ||
| PCT/EP2019/051245 WO2019141808A1 (en) | 2018-01-19 | 2019-01-18 | C5a receptor modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021511327A JP2021511327A (ja) | 2021-05-06 |
| JP2021511327A5 true JP2021511327A5 (cg-RX-API-DMAC7.html) | 2022-01-21 |
| JP7281470B2 JP7281470B2 (ja) | 2023-05-25 |
Family
ID=65023915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539797A Active JP7281470B2 (ja) | 2018-01-19 | 2019-01-18 | C5a受容体調節剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11685729B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3740477A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7281470B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111683937A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3087784A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019141808A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA124694C2 (uk) | 2018-01-10 | 2021-10-27 | Ідорсія Фармасьютікалз Лтд | 2,4,6,7-ТЕТРАГІДРОПІРАЗОЛО[4,3-d]ПІРИМІДИН-5-ОНОВІ ПОХІДНІ ТА СПОРІДНЕНІ СПОЛУКИ ЯК МОДУЛЯТОРИ РЕЦЕПТОРА C5A ДЛЯ ЛІКУВАННЯ ВАСКУЛІТУ ТА ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ |
| WO2019141803A1 (en) | 2018-01-19 | 2019-07-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
| US11685729B2 (en) | 2018-01-19 | 2023-06-27 | Idorsia Pharmaceuticals Ltd. | C5a receptor modulators |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2118117A1 (en) | 1993-02-18 | 1994-08-19 | Shigeki Fujiwara | Adenosine uptake inhibitor |
| KR100607634B1 (ko) | 1998-10-16 | 2006-08-02 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 퀴나졸리논 유도체 |
| PL347432A1 (en) | 1998-10-23 | 2002-04-08 | Hoffmann La Roche | Bicyclic nitrogen heterocycles |
| JO2355B1 (en) | 2003-04-15 | 2006-12-12 | ميرك شارب اند دوم كوربوريشن | Hereditary calcitonin polypeptide receptor antagonists |
| US7476665B2 (en) | 2003-06-26 | 2009-01-13 | Merck & Co., Inc. | Benzodiazepine CGRP receptor antagonists |
| WO2005019188A1 (ja) | 2003-08-22 | 2005-03-03 | Takeda Pharmaceutical Company Limited | 縮合ピリミジン誘導体およびその用途 |
| JP2007515458A (ja) | 2003-12-23 | 2007-06-14 | テイボテク・フアーマシユーチカルズ・リミテツド | Hivプロテアーゼ阻害剤の自己ミクロ乳化性薬剤送達システム |
| US20070292421A1 (en) * | 2005-07-28 | 2007-12-20 | Feinberg Bruce B | Method for treating preeclampsia |
| WO2007028789A1 (en) | 2005-09-07 | 2007-03-15 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Quinazoline derivatives as antiviral agents |
| US7834000B2 (en) | 2006-06-13 | 2010-11-16 | Vertex Pharmaceuticals Incorporated | CGRP receptor antagonists |
| EP2027106A2 (en) | 2006-06-13 | 2009-02-25 | Vertex Pharmaceuticals Incorporated | Cgrp receptor antagonists |
| CA2656507C (en) | 2006-07-17 | 2012-03-20 | Amgen Inc. | Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors |
| SA08280783B1 (ar) | 2007-01-11 | 2011-04-24 | استرازينيكا ايه بي | مشتقات بيريدوبيريميدين كمثبطات pde4 |
| DK2585064T3 (en) * | 2010-06-24 | 2017-07-24 | Chemocentryx Inc | C5aR antagonists |
| US20120143725A1 (en) | 2010-12-02 | 2012-06-07 | Vinimaya Inc. | Methods and systems for influencing search and shopping decisions in electronic procurement |
| GB201106814D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compounds |
| MX2016002544A (es) | 2013-09-04 | 2016-06-17 | Squibb Bristol Myers Co | Compuestos utiles como inmunomoduladores. |
| RS57508B1 (sr) | 2013-09-06 | 2018-10-31 | Aurigene Discovery Tech Ltd | 1,2,4-derivati oksadiazola kao imunomodulatori |
| WO2015044900A1 (en) | 2013-09-27 | 2015-04-02 | Aurigene Discovery Technologies Limited | Therapeutic immunomodulating compounds |
| CN114984016A (zh) * | 2015-03-13 | 2022-09-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
| UA124694C2 (uk) | 2018-01-10 | 2021-10-27 | Ідорсія Фармасьютікалз Лтд | 2,4,6,7-ТЕТРАГІДРОПІРАЗОЛО[4,3-d]ПІРИМІДИН-5-ОНОВІ ПОХІДНІ ТА СПОРІДНЕНІ СПОЛУКИ ЯК МОДУЛЯТОРИ РЕЦЕПТОРА C5A ДЛЯ ЛІКУВАННЯ ВАСКУЛІТУ ТА ЗАПАЛЬНИХ ЗАХВОРЮВАНЬ |
| WO2019141803A1 (en) | 2018-01-19 | 2019-07-25 | Idorsia Pharmaceuticals Ltd | C5a receptor modulators |
| US11685729B2 (en) | 2018-01-19 | 2023-06-27 | Idorsia Pharmaceuticals Ltd. | C5a receptor modulators |
-
2019
- 2019-01-18 US US16/963,143 patent/US11685729B2/en active Active
- 2019-01-18 CA CA3087784A patent/CA3087784A1/en active Pending
- 2019-01-18 EP EP19700614.1A patent/EP3740477A1/en not_active Withdrawn
- 2019-01-18 WO PCT/EP2019/051245 patent/WO2019141808A1/en not_active Ceased
- 2019-01-18 JP JP2020539797A patent/JP7281470B2/ja active Active
- 2019-01-18 CN CN201980009036.7A patent/CN111683937A/zh active Pending